Preview

Journal Biomed

Advanced search

Influence of Xylaria polymorpha (Pers.) Grev. Biotechnological Products on the Cardiovascular System

https://doi.org/10.33647/2074-5982-21-3-127-131

Abstract

Xylaria polymorpha mushrooms produce a wide variety of secondary metabolites with unique chemical structures and diverse biological activities. The antimicrobial, antioxidant, and anti-inflammatory properties of Xylaria polymorpha metabolites were previously reported. The present study shows that an in vitro obtained extract obtained from the mycelial biomass of Xylaria polymorpha (Pers.) Grev. exhibits a hypotensive effect, due to an increase in the elastic properties of the main arteries (primarily the root and ascending aorta) and an improvement in endothelial function. This process is accompanied by a decrease in energy costs during cardiac contraction and an increase in the functional reserves of the cardiovascular system.

About the Authors

M. Yu. Ravaeva
V.I. Vernadsky Crimean Federal University
Russian Federation

Marina Yu. Ravaeva - Cand. Sci. (Biol.), Assoc. Prof.

295007, Republic of Crimea, Simferopol, Academician Vernadsky Ave., 4



M. V. Nagorskaya
V.I. Vernadsky Crimean Federal University
Russian Federation

Mariya V. Nagorskaya

295007, Republic of Crimea, Simferopol, Academician Vernadsky Ave., 4



A. I. Sidyakin
V.I. Vernadsky Crimean Federal University
Russian Federation

Andrey I. Sidyakin - Cand. Sci. (Biol.).

295007, Republic of Crimea, Simferopol, Academician Vernadsky Ave., 4



N. I. Robu
V.I. Vernadsky Crimean Federal University
Russian Federation

Natalia I. Robu

295007, Republic of Crimea, Simferopol, Academician Vernadsky Ave., 4



References

1. Ostroumova O.D., Kochetkov A.I., Ostroumova T.M. Pulsovoye arterialnoye davleniye i kognitivnyye narusheniya [Pulse arterial pressure and cognitive impairment]. Rossijskij kardiologicheskij zhurnal [Russian Journal of Cardiology]. 2021;26(1):4317. (In Russian). DOI: 10.15829/1560-4071-2021-4317.

2. Boonphong S., Kittakoop P., Isaka M. Multiplolides A and B, New Antifungal 10-Membered Lactones from Xylaria m ultiplex. Journal of Natural Products. 2001;64(7):965–967.

3. Hacioglu N., Akata I., Dulger B. Antimicrobial potential of Xylaria polymorpha (Pers.) Grev. African Journal of Microbiology Research. 2011;5(6):728–730.

4. Healy P.C., Hocking A., Tran-Dinh N., Pitt J.I., Shivas R.G., Mitchell J.K., Kotiw M., Davis R.A. Xanthones from a microfungus of the genus Xylaria. Phytochemistry. 2004;65(16):2373–2378.

5. Jayasuriya H., Herath K.B., Ondeyka J.G., Polishook J.D., Bills G.F., Dombrowski A.W., Springer M.S., Siciliano S., Malkowitz L., Sanchez M., Guan Z., Tiwari S,. Stevenson D.W., Borris R.P., Singh S.B. Isolation and structure of antagonists of chemokine receptor (CCR5). Journal of Natural Products. 2004;67(6):1036–1038.

6. Lin Y., Wu X., Feng S., Jiang G., Luo J., Zhou S., Vrijmoed L.L., Jones E.B., Krohn K., Steingröver K., Zsila F. Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. The Journal of Organic Chemistry. 2001;66(19):6252– 6256.

7. Smith C.J., Morin N.R., Bills G.F., Dombrowski A.W., Salituro G.M., Smith S.K., Zhao A., MacNeil D.J. Novel sesquiterpenoids from the fermentation of Xylaria persicaria are selective ligands for the NPY Y5 receptor. The Journal of Organic Chemistry. 2002;67(14):5001–5004.


Review

For citations:


Ravaeva M.Yu., Nagorskaya M.V., Sidyakin A.I., Robu N.I. Influence of Xylaria polymorpha (Pers.) Grev. Biotechnological Products on the Cardiovascular System. Journal Biomed. 2025;21(3):127-131. (In Russ.) https://doi.org/10.33647/2074-5982-21-3-127-131

Views: 7


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-5982 (Print)
ISSN 2713-0428 (Online)